Home » Authors » Glen Harris

Articles by Glen Harris

Rigel Shares Skyrocket 224% With Success Of RA Drug

Dec. 14, 2007

Savient's Gout Drug Puricase Hits Endpoints In Dual Trials

Dec. 14, 2007

Competition For Few Compounds Drives Up Deal Costs, Complexity

Nov. 14, 2007

As Big Pharma Model Falters, Biotech Rides To The Rescue

Nov. 14, 2007

As Big Pharma Model Falters, Biotech Rides To The Rescue

Nov. 14, 2007

Competition For Few Compounds Drives Up Deal Costs, Complexity

Nov. 14, 2007

As Big Pharma Model Falters, Biotech Rides To The Rescue

Nov. 13, 2007

As Big Pharma Model Falters, Biotech Rides To The Rescue

Nov. 13, 2007

Targanta IPO Nets $59.9M To Advance Oritavancin

Oct. 11, 2007

Targanta IPO Nets $59.9M To Advance Oritavancin

Oct. 11, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 17, 2025
Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal
BioWorld
The J.P. Morgan (JPM) Healthcare Conference in San Francisco kicked off with a resounding bang as Johnson & Johnson (J&J) disclosed plans to acquire...
Proteomics study explores how protein changes influence disease
BioWorld Science
Fourteen global pharma companies are getting together to conduct the largest proteomics study to date, analyzing 600,000 blood samples held in the UK Biobank to...
Abbvie and Simcere enter a $1B T-cell engager deal
BioWorld Asia
Abbvie Inc. and Simcere Zaiming Pharmaceutical Co. Ltd. are part of the volley of large deals accompanying the opening of the 43rd annual J.P. Morgan Healthcare...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.